LAVA Therapeutics N.V. (NASDAQ: LVTX) Stock Information | RedChip

LAVA Therapeutics N.V. (NASDAQ: LVTX)

$1.6200
+0.1400 ( +8.00% ) 27.7K

LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.

Market Data

Open

$1.6200

Previous close

$1.4800

Volume

27.7K

Market cap

$41.55M

Day range

$1.4750 - $1.6300

52 week range

$1.3500 - $6.4700

SEC Filings

Form Type Description Pages Date
6-k Form 6-K 4 Aug 20, 2024
6-k Form 6-K 1 Jun 20, 2024
6-k Form 6-K 30 Jun 06, 2024
6-k Form 6-K 4 May 21, 2024
6-k Form 6-K 2 Mar 21, 2024
20-f Annual reports 116 Mar 20, 2024
6-k Form 6-K 4 Nov 16, 2023

Latest News

About US

Services

Stay Connected